KALVISTA PHARMACEUTICALS INC (KALV)

US4834971032 - Common Stock

11.07  -0.04 (-0.36%)

After market: 11.07 0 (0%)

Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to KALV. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 32.23. This target is 191.17% above the current price.
KALV was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about KALV.
In the previous month the buy percentage consensus was at a similar level.
KALV was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 11.0724.2435.7032.2340.95 - 118.97% 222.49% 191.17% 269.92%
Up and Down Grades
Date Firm Action Rating
2024-03-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-11 Needham Maintains Buy -> Buy
2024-02-14 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-13 Needham Maintains Buy -> Buy
2023-09-08 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-07-10 HC Wainwright & Co. Reiterate Buy -> Buy
2023-04-21 Needham Reiterate Buy
2023-03-10 HC Wainwright & Co. Reiterate Buy
2023-03-09 Needham Reiterate Buy
2023-02-03 SVB Leerink Maintains Outperform
2022-10-06 HC Wainwright & Co. Maintains Buy
2022-10-05 SVB Leerink Maintains Outperform
2022-10-04 Needham Maintains Buy
2022-07-08 Needham Maintains Buy
2022-07-08 SVB Leerink Maintains Outperform
2022-06-08 Stifel Maintains Buy
2022-03-11 Needham Maintains Buy
2021-12-10 Needham Maintains Buy
2021-02-18 Roth Capital Maintains Buy
2021-02-10 SVB Leerink Maintains Outperform
2021-02-10 HC Wainwright & Co. Maintains Buy